The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Now without typos.....
If contract rns are of little benefit, why don't all companies follow suit and save the rns fee. Just wait until revenue hits the bottom line and is reported in Results. Like we do!
Barking mad when figures and details we should know in a landgrab could propel the sp higher and earlier. Nobody is suggesting a flurry of rns for all wins. Material contracts, or cumulative wins with detail occasionally issued. The point is it is NOTHING for 18 long months in a landgrab without any explanation and if your view is the norm then this is without any question. Bizzare!!
I must ask all other companies why they bother to rns any contract wins. Just stay silent.
If contract rns are of little benefit, why don't all companies follow suit and save the end few. Just wait until revenue hits the bottom line and is reported in Results. Like we do!
Barking mad when figures and details we should know in a landgrab could propel the sp higher and earlier. Nobody is suggesting a flurry of rns for all wins. Selective material or cumulative wins with detail occasionally issued. The point is it is NOTHING for 18 long months in a landgrab without any explanation and if your view is the norm then without any question. Blizzard!!
I must ask all other companies why the bother!
Contract rns over 18 months ago had very little derail we were informed primarily because we were in litigation for most of that time and did not want to give financial or commercial details. That's not been an issue since settlement when we have stated we are in a landgrab - once again.
So like all other companies who win material contracts announce them with permitted detail. We should follow suit unless you can think of a reason remaining not to?
You fail to engage on the core obvious truth - ALL companies benefit from announcing contract wins that are notable. In our landgrab we gave not had even 1 rns contract win in 18 months. Frankly I am not interested if another company whose business and fundamentals I know nothing about doesn't see sp appreciation on contract rns. There could be lots of reasons like imminent cash call coming or x, y or z. In isolation I don't know why we cannot rns material contracts now with some detail and we are poorer for not doing so for such a long period. You fail to engage on the core - that it can't hurt to rns material contracts or shout about wins as it is a positive news item and material price sensitive contracts must be announced. It's not a good think to have 18 months and counting of silence and irrelevant to try to compare to a.n.other company and draw comparisons.
Well after this I hope so.
To Goggins and Twix. There are two points I wish to make. One is about contract announcements affecting the SP and the other is contracts in general.
Wonderful Contracts to not always improve the SP. I hold TP Group who are in aerospace and defense and supply kit and services. They are in a similar position to Yourgene in that their revenues have started to increase significantly recently and profit and dividends are, if not in sight, then just around the corner.
TPG has a forward contracted orderbook of 50% more than it's revenue which is some 50 Mil. In addition it's orderbook is growing faster than it's revenue. This acceleration has been notable in the last 18 months or so. however in spite of this terrific achievement the SP has stagnated at some 7p for 2 years.
If you look at it's contract announcements you will see that the headline says the amount of the contract and who it's with. The body of the announcement then gives the details and importantly the time scale. One can then evaluate the announcement. However by stating the partner the "capacity" of the partners is shown. IE are they both capable of fulfilling the contract - one by delivering and one by paying? By announcing the value and the duration of the contract they are demonstrating "consideration" - this is the willingness for one to deliver and one to pay. Capacity and Consideration are cornerstones of contracts and without them there is no contract.
Now let us look at the announcement that were common over 18 months ago with Primatha that you both miss. The counter signatories were largely anonymous so capacity could not be demonstrated. That doesn't mean they couldn't do it. No mention was made about sales projections or targets so no time scales were included and there was no monetary value mentioned. There were good reasons for this because of the staged sales channels. The end customer was a patient of a clinician who was a customer of the lab concerned. To complicated too accurately predict. Therefore no consideration was involved. Therefore no contract.
There where many announcements made by Primatha but they didn't seem to effect the SP in any meaningful and sustained way. However in the last 12 months in spite of you both being disappointed by a lack of them the SP has doubled!
I hope you both appreciate the above is based on facts. There might be an odd mistake so please feel free to comment.